• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗性作用信号节点可挽救 VHL 缺陷细胞中 AURKA 驱动的初级纤毛缺失。

Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells.

机构信息

Center for Precision Environmental Health, Baylor College of Medicine, One Baylor Plaza, BCM130, Houston, TX, 77030, USA.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.

出版信息

Sci Rep. 2021 May 17;11(1):10461. doi: 10.1038/s41598-021-89933-7.

DOI:10.1038/s41598-021-89933-7
PMID:34002003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8128866/
Abstract

Loss of primary cilia in cells deficient for the tumor suppressor von Hippel Lindau (VHL) arise from elevated Aurora Kinase A (AURKA) levels. VHL in its role as an E3 ubiquitin ligase targets AURKA for degradation and in the absence of VHL, high levels of AURKA result in destabilization of the primary cilium. We identified NVP-BEZ235, a dual PI3K/AKT and mTOR inhibitor, in an image-based high throughput screen, as a small molecule that restored primary cilia in VHL-deficient cells. We identified the ability of AKT to modulate AURKA expression at the transcript and protein level. Independent modulation of AKT and mTOR signaling decreased AURKA expression in cells confirming AURKA as a new signaling node downstream of the PI3K cascade. Corroborating these data, a genetic knockdown of AKT in cells deficient for VHL rescued the ability of these cells to ciliate. Finally, inhibition of AKT/mTOR using NVP-BEZ235 was efficacious in reducing tumor burden in a 786-0 xenograft model of renal cell carcinoma. These data highlight a previously unappreciated signaling node downstream of the AKT/mTOR pathway via AURKA that can be targeted in VHL-null cells to restore ciliogenesis.

摘要

缺乏抑癌基因 von Hippel Lindau(VHL)的细胞中初级纤毛的丧失是由于 Aurora Kinase A(AURKA)水平升高所致。VHL 作为一种 E3 泛素连接酶,可将 AURKA 靶向降解,而在 VHL 缺失的情况下,AURKA 水平升高会导致初级纤毛不稳定。我们在基于图像的高通量筛选中发现了 NVP-BEZ235,这是一种双重 PI3K/AKT 和 mTOR 抑制剂,它可以恢复 VHL 缺陷细胞中的初级纤毛。我们发现 AKT 能够在转录和蛋白水平上调节 AURKA 的表达。AKT 和 mTOR 信号的独立调节降低了细胞中的 AURKA 表达,证实 AURKA 是 PI3K 级联下游的一个新的信号节点。这些数据得到了证实,在 VHL 缺陷细胞中敲低 AKT 的基因可挽救这些细胞的纤毛形成能力。最后,使用 NVP-BEZ235 抑制 AKT/mTOR 在肾透明细胞癌的 786-0 异种移植模型中有效减少了肿瘤负担。这些数据突出了 AKT/mTOR 通路下游以前未被认识到的通过 AURKA 的信号节点,该节点可在 VHL 缺失的细胞中被靶向以恢复纤毛发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/7587944c62a7/41598_2021_89933_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/a64e124015a0/41598_2021_89933_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/e6662769023a/41598_2021_89933_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/df5594107cf7/41598_2021_89933_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/ad35f9f9bbfa/41598_2021_89933_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/7587944c62a7/41598_2021_89933_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/a64e124015a0/41598_2021_89933_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/e6662769023a/41598_2021_89933_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/df5594107cf7/41598_2021_89933_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/ad35f9f9bbfa/41598_2021_89933_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f935/8128866/7587944c62a7/41598_2021_89933_Fig5_HTML.jpg

相似文献

1
Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells.治疗性作用信号节点可挽救 VHL 缺陷细胞中 AURKA 驱动的初级纤毛缺失。
Sci Rep. 2021 May 17;11(1):10461. doi: 10.1038/s41598-021-89933-7.
2
β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma.β-连环蛋白将希佩尔-林道综合征与极光激酶A联系起来,并导致肾细胞癌中初级纤毛的缺失。
J Am Soc Nephrol. 2015 Mar;26(3):553-64. doi: 10.1681/ASN.2013090984. Epub 2014 Oct 13.
3
Bexarotene - a novel modulator of AURKA and the primary cilium in -deficient cells.贝沙罗汀——一种新型 AURKA 调节剂和原发性纤毛缺陷细胞中的主要纤毛。
J Cell Sci. 2018 Dec 14;131(24):jcs219923. doi: 10.1242/jcs.219923.
4
Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.抑制自噬增强了 PI3K/AKT/mTOR 抑制剂 NVP-BEZ235 在肾癌细胞中诱导的细胞凋亡。
Cell Biochem Funct. 2013 Jul;31(5):427-33. doi: 10.1002/cbf.2917. Epub 2012 Oct 22.
5
Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL.AURKA的泛素化与调控确定了VHL的一种不依赖缺氧的E3连接酶活性。
Oncogene. 2017 Jun 15;36(24):3450-3463. doi: 10.1038/onc.2016.495. Epub 2017 Jan 23.
6
PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.PTEN 抑制 YY1 诱导 von-Hippel-Lindau 缺失型肾细胞癌中的 HIF-2 活性。
Cancer Biol Ther. 2009 Jul;8(14):1389-401. doi: 10.4161/cbt.8.14.8880. Epub 2009 Jul 30.
7
VHL loss predicts response to Aurora kinase A inhibitor in renal cell carcinoma cells.VHL 缺失可预测肾细胞癌细胞对 Aurora 激酶 A 抑制剂的反应。
Mol Med Rep. 2018 Jul;18(1):1206-1210. doi: 10.3892/mmr.2018.9038. Epub 2018 May 17.
8
FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway.FoxO 转录因子促进 AKT Ser473 磷酸化,并响应 PI3K-AKT 通路的药理学抑制促进肾肿瘤生长。
Cancer Res. 2014 Mar 15;74(6):1682-93. doi: 10.1158/0008-5472.CAN-13-1729. Epub 2014 Jan 21.
9
Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models.对PI3K/AKT/mTOR(NVP-BEZ235)和Ras/Raf/MEK(AZD6244)通路的双重阻断可协同抑制原发性子宫内膜样子宫内膜癌培养物的生长,而NVP-BEZ235可减少相应异种移植模型中的肿瘤生长。
Gynecol Oncol. 2015 Jul;138(1):165-73. doi: 10.1016/j.ygyno.2015.04.028. Epub 2015 Apr 28.
10
NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.NVP-BEZ235,一种新型的双重 PI3K-mTOR 抑制剂,在人神经胶质瘤细胞中显示出抗神经胶质瘤活性,并降低替莫唑胺的化疗耐药性。
Cancer Lett. 2015 Oct 10;367(1):58-68. doi: 10.1016/j.canlet.2015.07.007. Epub 2015 Jul 15.

引用本文的文献

1
Primary cilia and actin regulatory pathways in renal ciliopathies.肾脏纤毛病中的初级纤毛与肌动蛋白调节途径
Front Nephrol. 2024 Jan 16;3:1331847. doi: 10.3389/fneph.2023.1331847. eCollection 2023.
2
Recent advances in the understanding of cilia mechanisms and their applications as therapeutic targets.纤毛机制理解方面的最新进展及其作为治疗靶点的应用。
Front Mol Biosci. 2023 Sep 14;10:1232188. doi: 10.3389/fmolb.2023.1232188. eCollection 2023.
3
Islet cilia and glucose homeostasis.胰岛纤毛与葡萄糖稳态。

本文引用的文献

1
The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma.NVP-BEZ235与瑞戈非尼在肝细胞癌中的协同抗癌作用
Molecules. 2020 May 25;25(10):2454. doi: 10.3390/molecules25102454.
2
PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth and .GNE-477 通过抑制 PI3K-Akt-mTOR 抑制肾细胞癌细胞生长和 。
Aging (Albany NY). 2020 May 18;12(10):9489-9499. doi: 10.18632/aging.103221.
3
Ciliary Genes in Renal Cystic Diseases.纤毛基因在肾脏囊性疾病中的作用。
Front Cell Dev Biol. 2022 Dec 1;10:1082193. doi: 10.3389/fcell.2022.1082193. eCollection 2022.
4
Aurora A and AKT Kinase Signaling Associated with Primary Cilia.极光 A 和 AKT 激酶信号与初级纤毛相关。
Cells. 2021 Dec 20;10(12):3602. doi: 10.3390/cells10123602.
Cells. 2020 Apr 8;9(4):907. doi: 10.3390/cells9040907.
4
The primary cilium: Its role as a tumor suppressor organelle.初级纤毛:作为肿瘤抑制细胞器的作用。
Biochem Pharmacol. 2020 May;175:113906. doi: 10.1016/j.bcp.2020.113906. Epub 2020 Mar 10.
5
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism.致癌信号与癌症代谢交界处的 PI3K-AKT 网络。
Nat Rev Cancer. 2020 Feb;20(2):74-88. doi: 10.1038/s41568-019-0216-7. Epub 2019 Nov 4.
6
Cellular signalling by primary cilia in development, organ function and disease.初级纤毛在发育、器官功能和疾病中的细胞信号转导。
Nat Rev Nephrol. 2019 Apr;15(4):199-219. doi: 10.1038/s41581-019-0116-9.
7
Bexarotene - a novel modulator of AURKA and the primary cilium in -deficient cells.贝沙罗汀——一种新型 AURKA 调节剂和原发性纤毛缺陷细胞中的主要纤毛。
J Cell Sci. 2018 Dec 14;131(24):jcs219923. doi: 10.1242/jcs.219923.
8
mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3β.mTOR 复合物 1 控制糖原合酶激酶 3β 的核定位和功能。
J Biol Chem. 2018 Sep 21;293(38):14723-14739. doi: 10.1074/jbc.RA118.002800. Epub 2018 Jul 30.
9
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer.激酶组重排揭示 AURKA 限制乳腺癌中 PI3K 通路抑制剂的疗效。
Nat Chem Biol. 2018 Aug;14(8):768-777. doi: 10.1038/s41589-018-0081-9. Epub 2018 Jun 25.
10
Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1.双重 mTOR/PI3K 抑制剂 NVP-BEZ235 抑制结直肠癌细胞生长并显示对 4E-BP1 的差异抑制作用。
Oncol Rep. 2018 Aug;40(2):1083-1092. doi: 10.3892/or.2018.6457. Epub 2018 May 22.